Closing down: Transcatheter closure of intracardiac defects and vessel embolisations

Heart

Volumn 90, Issue 12, 2004, Pages 1505-1510

  Piéchaud, Jean François ^a  

^a INSTITUT HOSPITALIER JACQUES CARTIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DACRON; NITINOL; POLITEF;

ARTIFICIAL EMBOLISM; BALLOON CATHETER; COLLATERAL CIRCULATION; CORONARY ARTERY FISTULA; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFERIOR CAVA VEIN; INTERVENTIONAL RADIOLOGY; LUNG ARTERIOVENOUS SHUNT; LUNG SEQUESTRATION; LUNG VEIN; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; REVIEW; SUPERIOR CAVA VEIN; TREATMENT INDICATION;

COLLATERAL CIRCULATION; CORONARY VESSELS; DUCTUS ARTERIOSUS, PATENT; EMBOLIZATION, THERAPEUTIC; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; VASCULAR FISTULA;

EID: 10344247121     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.016071     Document Type: Review

References (22)

1. Gibbs JL. Interventional catheterisation. Opening up I: the ventricular outflow tracts and great arteries. Heart 2000;83:111-15.
2. Gibbs JL. Interventional catheterisation. Opening up II: venous return, the atrial septum, the arterial duct, aortopulmonary shunts, and aortopulmonary collaterals, Heart 2000;83:237-40.
3. Rashkind WJ, Mullins CE, Hellenbrand WE, et al. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA occluder system. Circulation 1987;75:583-92.
4. Hijazi ZM, Geggel RL. Transcatheter closure of large patent ductus arteriosus (> or = 4 mm) with multiple Gianturco coils: immediate and mid-term results. Heart 1996;76:536-40.
5. Masura J, Walsh KP, Thanopoulous B, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol 1998;31:878-82. First clinical study of the new PDA Amplatzer device, involving 24 patients with a relatively large ductus. Complete closure was obtained in one third of the cases, and trivial to small shunts in the others. At 24 hours Doppler revealed complete closure in all. This initial study shows the true efficacy of this new device.
6. Carminati M, Giusti S, Hausdorf G, et al. A European multicentric experience using the CardioSeal and Storflex double umbrella devices to close interatrial communications holes witfiin the oval fossa. Cardiol Young 2000;10:519-26. This paper presents the only published results of a multicentre study using the CardioSEAL and STARFlex devices in a series of 117 cases. Apart from device embolisation the main issue was device arm fracture which occurred in large devices, but without related complications.
7. Carminati M, Chessa M, Butera G, et al. Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up. J Interv Cardiol 2001;14:319-24.
8. Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997;42:388-93. Initial human experience with the new Amplatzer septal occluder. This study involved 30 patients including adults. The mean stretched diameter of the ostium secundum atrial defect was 14 mm (7-19 mm). The device was always well implanted with complete closure in 17 cases and trivial shunt in 10. There were no complications during the procedure and follow up. This study marked the beginning of the Amplatzer septal occluder story.
9. Zahn EM, Wilson N, Cutright W, et al. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 2001;104:711-6.
10. Sideris EB, Sideris CE, Stamatelopoulos SF, et al. Transcatheter patch occlusion of experimental atrial septal defects. Catheter Cardiovasc Interv 2002;57:404-7.
11. Omeish A, Hijazi ZM. Transcatheter closure of atrial septal defects in children & adults using the Amplatzer septal occluder. J Interv Cardiol 2001;14:37-44.
12. Harper RW, Mottram PM, McGaw DJ. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv 2002;57:508-24. Extensive paper on ASD closure using the Amplatzer device. Indications, technical aspects of a normal procedure, including sizing, echocardiographic monitoring, and deployment of the devices, are described. Specific problems of patent foramen avale are reviewed.
13. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-5. This group in Milan has a wealth of experience in ASD closure and has extensively published its results. This paper summarises the complications in a cohort of 417 cases of implantation using the two major ASD devices, and concludes that the procedure is safe.
14. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9. This paper summarises the clinical implications of the patent foramen avale and the indications for closure, with many important references quoted.
15. Piechaud JF. Hypoxemia related to right-to-left shunting through a patent foramen ovale: successful percutaneous treatment with the CardioSeal device. J Interv Cardiol 2001;14:57-60.
16. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003;16:39-42.
17. Lock JE, Block PC, McKay RG, et al. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361-8.
18. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, et al. Transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol 1999;33:1395-9. The muscular VSD closure with a new Amplatzer device in a small initial number of cases. Successful implantation and complete closure was achieved in all cases, and the only complication reported was a transient left bundle branch block in two of six cases.
19. Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv 2002;56:508-15.
20. Piechaud JF. Percutaneous closure of mitral paravalvular leak. J Interv Cardiol 2003;16:153-5. Description at the technical aspects of the closure of paravalvular leak in the mitral position. No clinical data are presented.
21. Armsby LR, Keane JF, Sherwood MC, et al. Management of coronary artery fistulae. Patient selection and results of transcatheter closure. J Am Coll Cardiol 2002;39:1026-32.
22. Chessa M, Drago M, Krantunkov P, et al. Differential diagnosis between patent foramen ovale and pulmonary arteriovenous fistula in two patients with previous cryptogenic stroke caused by presumed paradoxical embolism. J Am Soc Echocardiogr 2002;15:845-6.